Masters of Longevity Editorial
ApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.ApoBCardiovascular riskCholesterol
The Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.Regeneron PharmaceuticalsMyostatin inhibitorsActivin A inhibitors-640x360.webp&w=1920&q=75)
When Health Tracking Becomes Self-SurveillanceWearables, sleep scores and biomarkers can improve decisions. They can also turn normal variation into threat. The point is not to measure less, but to measure in a way that builds resilience. Here's some practical advice.Health TrackingWearablesLongevity Psychology
Midjourney’s Strange Leap Into Preventive HealthMidjourney's full-body ultrasound scanner is a strange, ambitious signal of where preventive health may be going. But more body data does not automatically mean better medicine.AI in HealthcarePreventive HealthDiagnostics
Wearables, Nearables, And The New Body-Data StackWearables and nearables are moving health data beyond the wrist into patches, rings, shoes, ingestibles, intimate devices, beds, rooms, and therapeutic systems. We mapped 130+ products to understand where body data is going next.WearablesBiomarkersLongevity Tech
SOND Dreambuds Aim to Turn Sleep Tracking Into Real-Time Sleep CoachingThe Boston startup founded by MIT graduates and Bose’s former sleep products lead is introducing sensor-packed earbuds that try to adapt sleep audio in real time.Sleep techWearablesAI coaching
Mapping the Swiss Longevity ClinicsSwitzerland does not lack longevity clinics. It lacks orchestration. This report maps 40 Swiss providers across five clinical arenas and examines the strategic gaps, white spaces, and platform opportunities that will determine whether Switzerland’s clinical longevity market remains fragmented or evolves into a more integrated, data-driven care ecosystem.
Creatine's Second Act: From Gym Supplement to Healthy-Aging ToolOnce known mainly as a muscle supplement, creatine is now being studied for cognition, aging, recovery and metabolic resilience. The evidence is promising, but the smartest use is still simple: daily monohydrate, protein-rich food and resistance training.CreatineBrain HealthHealthy Aging
From Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.Market viewEverstride
The Hardware of Longevity: Why We Are Ready for the Cellular ResetAging is often framed as inevitable wear and tear. In this guest perspective, Michael Fossel argues that telomeres, cellular maintenance, and gene delivery could redefine how we think about age-related disease.Voices in Longevity
New Hilo Report Highlights the UK’s Blood Pressure Awareness GapThe 2025 Hilo Blood Pressure Report reveals major gaps in public understanding, diagnosis, and monitoring of hypertension, especially across age, income, and education groups.
Who Buys Longevity?The longevity industry often speaks about one generic “longevity consumer.” In reality, demand is fragmented across distinct client groups, each with its own fears, aspirations, evidence standards, and willingness to pay. For anyone building, investing in, or advising the healthspan economy, segmentation is becoming a strategic necessity. This report provides a practical model for understanding who these clients are, what they seek, and how the market can serve them with greater precision.MoL Research ReportLongevity Taxonomy
A Global Rally for Life ExtensionOn April 8, the streets of Madrid were not the scene of an ordinary protest. Citizens, scientists, entrepreneurs, and healthcare professionals gathered for the Longevity March, a global mobilization that connected Madrid simultaneously with major cities such as Brussels, London, Paris, and Berlin in Europe; Caracas, Mexico City, and San Francisco in the Americas; and Abu Dhabi and Tel Aviv in the Middle East, even during the current war in the region. The message was clear and urgent: aging must be treated as a global political and scientific priority.
Beyond the Hype: What Science Really Says About Your Gut BacteriaThe gut microbiome has become a scientific and public fascination, with new studies and health claims emerging daily. While diet is often cited as the key factor shaping gut bacteria, research suggests a far more complex picture. With over 200 variables influencing an individual’s microbiome and only a fraction of its variability explained, the idea of a universally “healthy” gut remains elusive. Popular microbiome tests and interventions may not tell the whole story – especially when stool samples only offer a partial snapshot of the vast intestinal ecosystem. This article explores the intricate relationship between diet, microbiome diversity, and health, challenging common assumptions and highlighting the unanswered questions in this rapidly evolving field.MicrobiomeNutritionPreventive Health
Domestic Longevity Adoption in Switzerland and The “Sick Care” ProblemThe Swiss healthcare system is frequently cited as one of the most robust, high-quality, and accessible systems in the world. However, a closer examination of its financial architecture reveals a system fundamentally misaligned with the emerging paradigm of longevity and preventive health. It’s a system optimized for “Sick Care” – the management of acute pathology and established chronic disease – but structurally fails to preserve health capital. This report dissects the structural and economic forces behind this dynamic and explores what would need to change to enable a transition toward a prevention- and longevity-driven healthcare system.HealthcarePrevention